Abstract
Anemia is a risk factor related to morbidity and mortality in patients with chronic heart failure (HF). Less is known about its influence in patients in an early stage of HF. Our aim is to investigate the prognostic role of anemia in patients initially hospitalized for acute HF. We reviewed all consecutive patients admitted within a 18-month period with a main diagnosis of acute HF. We collected demographic, clinical and treatment data. Anemia is defined as Hemoglobin <12/13 g/dL upon admission in female/male patients, respectively. 719 patients were included (55.5% female), with a mean age of 78.7 ± 9 years. Anemia was present in 59.6% of patients upon admission, with a mean Hb of 10.4 ± 1.4 g/dL. Multivariate analysis confirms the relationship between the presence of anemia and older age, a previous diagnostic history of diabetes, and the presence of chronic kidney disease. In-hospital mortality is similar for anemic and non-anemic patients (6.8 vs 3.8%, p = n.s.) However, the difference is significant when one-year mortality is evaluated (31% in anemic patients vs 19% in non-anemic patients, p < 0.001). Cox regression analysis confirms the association between anemia and higher risk of one-year mortality, as well as with older age and a higher Charlson comorbidity index. Our study confirms that the presence of anemia is an independent factor for mid-term (1-year) mortality even in patients experiencing a first admission due to acute HF.
Similar content being viewed by others
References
Stamos TD, Silver MA (2010) Management of anemia in heart failure. Curr Opin Cardiol 25:148–154. doi:10.1097/HCO.0b013e3283357fe0
Cattadori G, Agostoni P, Corrà U, Sinagra G, Veglia F, Salvioni E, Bonomi A, La Gioia R, Scardovi AB, Ferraironi A, Emdin M, Metra M, Di Lenarda A, Limongelli G, Raimondo R, Re F, Guazzi M, Belardinelli R, Parati G, Caravita S, Magrì D, Lombardi C, Frigerio M, Oliva F, Girola D, Mezzani A, Farina S, Mapelli M, Scrutinio D, Pacileo G, Apostolo A, Iorio A, Paolillo S, Filardi PP, Gargiulo P, Bussotti M, Marchese G, Correale M, Badagliacca R, Sciomer S, Palermo P, Contini M, Giannuzzi P, Battaia E, Cicoira M, Clemenza F, Minà C, Binno S, Passino C, Piepoli MF (2016) Heart failure and anemia: effects on prognostic variables. Eur J Intern Med 37:56–63. doi:10.1016/j.ejim.2016.09.011
Triposkiadis F, Giamouzis G, Parissis J, Starling RC, Boudoulas H, Skoularigis J, Butler J, Filippatos G (2016) Reframing the association and signi fi cance of co-morbidities in heart failure. Eur J Heart Fail 30:744–758
Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, Tsagalou EP, Maroulidis GD, Alexopoulos GP, Kanakakis JE, Anastasiou-Nana MI (2006) Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 48:2485–2489. doi:10.1016/j.jacc.2006.08.034
Meara EO, Rouleau JL, White M, Roy K, Blondeau L, Ducharme A, Neagoe PE, Sirois MG, Lavoie J, Racine N, Liszkowski M, Madore F, Tardif JC, De Denus S (2014) Heart failure with anemia novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes. Circ Hear Fail 7:773–781. doi:10.1161/CIRCHEARTFAILURE.114.001100
Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, Febo O, Ferrari R, Fucili A, Moratti R, Tramarin R, Tavazzi L (2005) Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 26:2232–2237. doi:10.1093/eurheartj/ehi388
Ather S, Chan W, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA, Wehrens XHT, Deswal A (2012) Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 59:998–1005. doi:10.1016/j.jacc.2011.11.040
Moe GW, Ezekowitz JA, O’Meara E, Lepage S, Howlett JG, Fremes S, Al-Hesayen A, Heckman GA, Abrams H, Ducharme A, Estrella-Holder E, Grzeslo A, Harkness K, Koshman SL, McDonald M, McKelvie R, Rajda M, Rao V, Swiggum E, Virani S, Zieroth S, Arnold JMO, Ashton T, D’Astous M, Chan M, De S, Dorian P, Giannetti N, Haddad H, Isaac DL, Kouz S, Leblanc MH, Liu P, Ross HJ, Sussex B, White M (2015) The 2014 Canadian cardiovascular society heart failure management guidelines focus update: anemia, biomarkers, and recent therapeutic trial implications. Can J Cardiol 31:3–16. doi:10.1016/j.cjca.2014.10.022
Kalra PR, Collier T, Cowie MR, Fox KF, Wood DA, Poole-Wilson PA, Coats AJS, Sutton GC (2003) Haemoglobin concentration and prognosis in new cases of heart failure. Lancet. doi:10.1016/S0140-6736(03)13912-8
Formiga F, Chivite D, Castañer O, Manito N, Ramón JM, Pujol R (2006) Anemia in new-onset congestive heart failure inpatients admitted for acute decompensation. Eur. J. Intern. Med. doi:10.1016/j.ejim.2005.11.015
McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:1441–1446. doi:10.1056/NEJM197112232852601
Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F, Disease K (2007) Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 772:766–772. doi:10.1373/clinchem.2006.077180
WHO Scientific Group on Nutritional Anaemias (1968) World Health Organization., Nutritional anaemias: report of a WHO scientific group (meeting held in Geneva from 13 to 17 March 1967). http://whqlibdoc.who.int/trs/WHO_TRS_405_rus.pdf
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 40:373–383. doi:10.1016/0021-9681(87)90171-8
Díez-Ló Pez C, Lupó J, De Antonio M, Zamora E, Domingo M, Santesmases J, Troya M-I, Boldó M, Bayes-Genis A (2016) Hemoglobin Kinetics and Long-term Prognosis in Heart Failure Ciné tica de la hemoglobina y pronó stico a largo plazo en insuficiencia cardiaca. Rev Esp Cardiol. doi:10.1016/j.rec.2016.02.028
Young JB, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O’Connor CM, She L, Sun JL, Yancy CW, Fonarow GC (2008) Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (Insight from the OPTIMIZE-HF Registry). Am J Cardiol. doi:10.1016/j.amjcard.2007.07.067
Galvao M, Kalman J, Demarco T, Fonarow GC, Galvin C, Ghali JK, Moskowitz RM (2006) Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the acute decompensated heart failure national registry (ADHERE). J Card Fail. doi:10.1016/j.cardfail.2005.09.005
Caughey MC, Avery CL, Ni H, Solomon SD, Matsushita K, Wruck LM, Rosamond WD, Loehr LR (2014) Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC Study Community Surveillance) HHS Public Access. Am J Cardiol 114:1850–1854. doi:10.1016/j.amjcard.2014.09.024
Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361:2436–2448. doi:10.1056/NEJMoa0908355
Ponikowski P, Van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh T, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD (2015) Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J 36:657–668. doi:10.1093/eurheartj/ehu385
Jankowska EA, Tkaczyszyn M, Suchocki T, Drozd M, von Haehling S, Doehner W, Banasiak W, Filippatos G, Anker SD, Ponikowski P (2016) Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. Eur J Heart Fail. doi:10.1002/ejhf.473
Hfa A, Voors AA, Germany SDA, Uk JGFC, Uk AJSC, Harjola V, Germany VF, Poland EAJ, Uk PN, Germany BP, Uk JPR, Rosano GMC, Rutten FH (2016) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution:2129–2200. doi:10.1093/eurheartj/ehw128
Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJV, O’Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ (2013) RED-HF Committees, RED-HF Investigators, Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 368:1210–1219. doi:10.1056/NEJMoa1214865
Silverberg DS, Wexler D, Blum M, Tchebiner JZ, Sheps D, Keren G, Schwartz D, Baruch R, Yachnin T, Shaked M, Schwartz I, Steinbruch S, Iaina A (2003) The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant 18:141–146. doi:10.1093/ndt/18.1.141
Vullaganti S, Goldsmith J, Teruya S, Alvarez J, Helmke S, Maurer MS (2014) Cardiovascular effects of hemoglobin response in patients receiving epoetin alfa and oral iron in heart failure with a preserved ejection fraction. J Geriatr Cardiol 11:100–105. doi:10.3969/j.issn.1671-5411.2014.02.002
Berry C, Poppe KK, Gamble GD, Earle NJ, Ezekowitz JA, Squire IB, Mcmurray JJV, Mcalister FA, Komajda M, Swedberg K, Maggioni AP, Ahmed A, Whalley GA, Doughty RN, Tarantini L (2016) Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis. QJM 109:377–382. doi:10.1093/qjmed/hcv087
Lupón J, Urrutia A, González B, Herreros J, Altimir S, Coll R, Prats M, Rey-Joly C, Valle V (2005) Prognostic significance of hemoglobin levels in patients with heart failure. Rev. Española Cardiol. 58:48–53. http://www.ncbi.nlm.nih.gov/pubmed/15680131
Ezekowitz JA, McAlister FA, Armstrong PW (2003) Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12065 patients with new-onset heart failure. Circulation. doi:10.1161/01.CIR.0000052622.51963.FC
Bueno H, Ross JS, Wang Y, Chen J, Vidán MT, Normand S-LT, Curtis JP, Drye EE, Lichtman JH, Keenan PS, Kosiborod M, Krumholz HM, Krumholz Y (2010) Trends in length of stay and short-term outcomes among medicare patients hospitalized for heart failure: 1993–2008. JAMA 303:2141–2147. doi:10.1001/jama.2010.748
Tuppin P, Cuerq A, De Peretti C, Fagot-Campagna A, Danchin N, Juillière Y, Alla F, Allemand H, Bauters C, Drici MD, Hagège A, Jondeau G, Jourdain P, Leizorovicz A, Paccaud F (2014) Two-year outcome of patients after a first hospitalization for heart failure: a national observational study. Arch Cardiovasc Dis. doi:10.1016/j.acvd.2014.01.012
Acknowledgements
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Statement of human and animal rights
This article does not contain any studies with animals performed by any of the authors. The ethics committee of the Bellvitge University Hospital approved the overall protocol.
Informed consent
For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Migone de Amicis, M., Chivite, D., Corbella, X. et al. Anemia is a mortality prognostic factor in patients initially hospitalized for acute heart failure. Intern Emerg Med 12, 749–756 (2017). https://doi.org/10.1007/s11739-017-1637-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-017-1637-5